Brief: Botanix Pharmaceuticals Posts Net Loss Attributable A$86.4 Million
29/08/2025 11:28
Aug 29 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX: FY NET LOSS ATTRIBUTABLE A$86.4 MILLION FY REVENUES FROM CUSTOMER SALES A$5.8 MILLION Further company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million